The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Characteristics of Toxicity Occurring in Outpatients at Korean Medical Clinics in Korean

한방의료기관이용환자의 부작용 및 독성발생의 특성 - 2011년 한방의료이용실태조사(보건복지부)를 중심으로 -

  • Lee, Ki-Bum (Dep. of Medicine, Chungbuk University) ;
  • Park, Yeongchul (GLP Center, Catholic University of Daegu) ;
  • Lee, Sundong (Dept. of Preventive Korean Medicine, School of Korean Medicine, Sangji University)
  • 이기범 (충북대학교 의과대학) ;
  • 박영철 (대구카톨릭대학교 GLP센터) ;
  • 이선동 (상지대학교 한의과대학 예방의학교실)
  • Received : 2016.03.02
  • Accepted : 2016.03.30
  • Published : 2016.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Research Methods: This research analyzed the data on those aged 20 and older from the Report on Korean Medicine Usage Research, which was conducted in 2011. The definitions of toxicity were defined by the presence of toxicity listed in the survey. The questions used in analysis were sex, age, household income, health insurance, medical fees, satisfaction rates on treatments, as well as the types of diseases and the presence of toxicity from treatments. The analysis was done through frequency analysis using SAS 9.2 and Fisher's Exact Test. Results: Toxicity occurred in 2.1% patients out of the 3518 studied. The types of toxicity were skin problems, such as hives and pruritus (34.7%), gastrointestinal problems (20.8%), neurological diseases (4.2%), liver(1.4%), kidney toxicity(1.4%), and others (22.2%). There were no differences in toxicity by sex, age, household income and the types of health insurances. However, toxicity were positively correlated with the increase in standard of education (p=0.0124). In addition, as treatment costs increased (p<0.0001) and satisfaction rates decreased, toxicity increased (p<0.0001). Toxicity increased in patients with low back pain (p=0.0429), hwabyung (p=0.0392), lumbar sprain (p=0.0004), correction body type (p=0.0118), growth (p=0.0045), and from motor accidents (p=0.0448). In logistic regression analysis, Toxicity were positively correlated with medical fees, and cancer treatment and negatively correlated with satisfaction rate on treatments. Conclusion: The toxicity that occurred in outpatients who used Korean medical clinics mostly happened in skin, digestive organs, nerves, livers, and kidneys toxicity. The occurrences differed by the Educational lengths, expensive costs of treatments, low satisfaction rates of the treatments, and cancer.

Keywords

References

  1. Wikipedia. Side effect. 2014. Available at:URL: https://en.wikipedia.org/wiki/Side_effect.
  2. U.S. Department Of Health and Human Services, Traditional Chinese Medicine: An Introduction. 2010
  3. World Health Organization. New WHO guidelines to promete proper use of alternative medicines. 2004.
  4. Ko SG, Jang BE, Choi JS. ADR of Herbal Medicines. Korean Journal of Oriental Physiology &Pathology. 2004;18(4):957-964.
  5. Zhou S, Koh HL, Gao Y, Gong ZY, Lee EJD, Herbal bioactivation : The good, the bad and the ugly. Life Science. 2004;74:935-968. https://doi.org/10.1016/j.lfs.2003.09.035
  6. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicine. Trends in pharmacological sciences. 2002;23(3):136-139. https://doi.org/10.1016/S0165-6147(00)01972-6
  7. Bensoussan A, Myers SP, Drew AK, Whyte IM, Dawson AH. Development of a Chinese herbal medicine toxicology database. Journal of Toxicology and Clinical Toxicology. 2002;40(2):159-167. https://doi.org/10.1081/CLT-120004404
  8. Greensfelder L. Alternative medicine. Herbal product linked to cancer. Science. 2000;288:1946.
  9. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. NEJM. 2000;343:1833-1838. https://doi.org/10.1056/NEJM200012213432502
  10. Kessler DA. Cancer and herbs. NEJM 2000;342:1742-1743. https://doi.org/10.1056/NEJM200006083422309
  11. McRae CA, Agarwal K, Mutimer D, Bassendine MF. Hepatitis associated with Chinese herbs. European Journal of Gastroenterology and Hepatology. 2002;14:669-562.
  12. Stedman C. Herbal hepatotoxicity. Seminars in Liver Disease. 2002;22(2):195-206. https://doi.org/10.1055/s-2002-30104
  13. Villegas JF, Barabe DN, Stein RA, Lazar E. Adverse effects of herbal treatment of cardiovascular disease: what the physician must know. Heart Disease. 2001;3(3):169-175. https://doi.org/10.1097/00132580-200105000-00007
  14. Zaacks SM, Klein L, Tan CD, Rodriguez ER, Leikin JB. Hypersensitivity myocarditis associated with ephedra use, J of Toxico and Clin Toxicol. 1999;37(4):485-489. https://doi.org/10.1081/CLT-100102440
  15. Woo YJ, Chung SY, Park BJ. Current Status of Spontaneous Adverse Reactions Reporting System on Herbal Medicine in China, Japan, Korea and WHO. J. Int. Korean Med. 2014:35(2)111-118.
  16. Ministry of Health and Welfares. Usage and Consumption of Korean Medicine. 2011.
  17. Park TS, Lee SY. An introduction to categorical data analysis. Freeaca. 1999.
  18. Yoo TW, Kim BI, Kim JB, Kim DJ, Kim JW, Baik SK, et al. The Survey for the Actual Condition of Drug Medication and Development of Health Care Cost Associated with Toxic Liver Injury in Korean; A Multicenter Study for the Detection and the Development of Nationwide Reporting System of Toxic Liver Injury.The Korean Journal of Hepatology. 2007;13(1):34-43.
  19. Seo JC, Jeon WJ, Park SS, Kim SH, Lee KM, Chae HB, et al. Clinical experience of 48 acute toxic hepatitis patients. The Korean Journal of Hepatology 2006;12(1):74-81.
  20. Jang JS, Seo EG, Han C, Chae HB, Kim SJ, Lee JD, et al. Four cases of toxic liver injury associated with dictamnus dasycarpus. The Korean Journal of Hepatology. 2008;14(1):206-212. https://doi.org/10.3350/kjhep.2008.14.2.206
  21. Ministry of Health and Welfares. Usage and Consumption of Korean Medicine. 2014.
  22. Korean Institute for Health and Social Affairs. Usage and Consumption of Korean Medicine and Perception in Korea. 2012.
  23. Rolf T, Axel E. Herbal hepatotoxicity in traditional and modern medicine: actual key issue and new encouraging steps. Frontiers in Pharmacology. 2015;6:72.
  24. Li Z, Jingbo Y, Xinmin L, Zuguang Y, Xiaohui Y. Ronald Meyboom, Kelvin Chan, Debbie Shaw, Pierre Duez, Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: Current status and future perspective. Journal of Ethnopharmacology. 2012;140:519-525. https://doi.org/10.1016/j.jep.2012.01.058
  25. Choi HJ. The side effects of using herbal medicine with western medicine. Jornal of Korean society of hospital pharmacists. 2003;20(2):1-9.
  26. Kim YH, Kim JH. The Benefits of the National Health Insurance and Oriental Medical Services. The Journal of Oriental Medical Preventive. 2007;11(1):139-151.
  27. Kim NJ. Expand and development insurance coverage of Korean traditional medicine. Korea Institute of Oriental Medicine. 1996.
  28. Shin YD. Research on the present coverage of health insurance of Korean traditional medicine and its activation Plan. Kyung Hee University. 2000.
  29. Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, et al. Specialized Committee for Drung-Induced Liver Disease Chinese Pharmacological Society. Comparison between Chinese herbal medicine and western medicine-induced liver injury of 1985 patients. Journal of Gastroenterology and Hepatology. 2016.

Cited by

  1. hERG 칼륨 채널 매개성 HEK 293 세포를 이용한 한약 처방의 심장 독성 평가 연구 vol.40, pp.2, 2016, https://doi.org/10.13048/jkm.19020
  2. 알코올성 간질환에 대한 한의학 연구 경향 분석 : 국내논문을 중심으로 vol.40, pp.3, 2019, https://doi.org/10.22246/jikm.2019.40.3.458
  3. 인진오령산 투여가 상승된 간화학 수치에 미치는 영향 : 후향적 차트 리뷰 vol.40, pp.3, 2016, https://doi.org/10.22246/jikm.2019.40.3.478
  4. 한의 외래서비스 이용자의 동일 증상에 대한 타 의료기관 이용 경험과 다빈도 질환 분석: 2017년 한방의료이용 실태조사를 이용하여 vol.23, pp.3, 2016, https://doi.org/10.25153/spkom.2019.23.3.002
  5. 우리나라의 한약 부작용 규모 추정 vol.24, pp.1, 2016, https://doi.org/10.25153/spkom.2020.24.1.003